We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

86 hedge funds and large institutions have $588M invested in Q32 Bio in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 40 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

383% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 6

300% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 10

30% more funds holding

Funds holding: 66 → 86 (+20)

0.41% more ownership

Funds ownership: 3.42% → 3.83% (+0.41%)

8% less capital invested

Capital invested by funds: $640M → $588M (-$52.4M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
86
Holders Change
+20
Holders Change %
+30.3%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
29
Increased
40
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
+$30.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$19.5M
3
BlackRock
BlackRock
New York
+$14.9M
4
State Street
State Street
Massachusetts
+$13.1M
5
DM
Deerfield Management
New York
+$11.6M

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$4.46M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$2.64M
3
Franklin Resources
Franklin Resources
California
-$2.42M
4
MWNA
Marshall Wace North America
New York
-$1.78M
5
SIM
Spark Investment Management
New York
-$450K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$113M +$11.6M +29,629 +10%
Temasek Holdings
2
Temasek Holdings
Singapore
$63M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$42.1M +$923K +2,349 +2%
BlackRock
4
BlackRock
New York
$40.8M +$14.9M +37,926 +49%
RI
5
RTW Investments
New York
$40.2M +$6.95M +17,679 +18%
JP Morgan Chase
6
JP Morgan Chase
New York
$38.7M +$553K +1,406 +1%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$38.3M +$19.5M +49,720 +84%
BG
8
Bellevue Group
Switzerland
$27.4M +$30.6M +77,896 New
VC
9
Vivo Capital
California
$22.7M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$19.9M +$7.77M +19,772 +54%
State Street
11
State Street
Massachusetts
$17.5M +$13.1M +33,233 +201%
VM
12
VV Manager
Massachusetts
$15.1M – – –
CC
13
Casdin Capital
New York
$14.6M +$8.62M +21,945 +113%
RSCM
14
Rock Springs Capital Management
Maryland
$8.32M +$1.2M +3,055 +15%
PM
15
Prosight Management
Texas
$7.22M +$8.06M +20,503 New
Franklin Resources
16
Franklin Resources
California
$7.12M -$2.42M -6,161 -23%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$6.23M +$3.27M +8,333 +89%
Lord, Abbett & Co
18
Lord, Abbett & Co
New Jersey
$6.11M -$2.64M -6,725 -28%
CAM
19
Cormorant Asset Management
Massachusetts
$5.87M +$6.55M +16,667 New
Northern Trust
20
Northern Trust
Illinois
$5.02M +$1.52M +3,871 +37%
GTP
21
Global Thematic Partners
New York
$4.28M +$1.16M +2,953 +32%
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$4M +$4.46M +11,344 New
Charles Schwab
23
Charles Schwab
California
$2.85M +$1.67M +4,258 +111%
EAM
24
Erste Asset Management
Austria
$2.69M +$2.18M +5,556 +263%
Victory Capital Management
25
Victory Capital Management
Texas
$2.59M +$1.09M +2,776 +61%
1
2 3 4

QTTB Hedge Fund Activity: Q2 2019 in Review

86 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2019, worth a combined $588M — down 8.2% from $640M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new QTTB positions and 6 closed out — a net gain of 23 holders — while 40 added to existing stakes and 10 trimmed.

The largest buyer was Bellevue Group, opening a new position worth an estimated $30.6M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $4.46M sold.

  • 86 institutional investors held Q32 Bio (QTTB) as of Q2 2019, up from 66 in Q1 2019.
  • Funds reported $588M of Q32 Bio stock for Q2 2019, down 8.2% quarter-over-quarter.
  • 29 funds opened new Q32 Bio positions in Q2 2019 and 6 closed out, a net change of +23 holders.
  • The largest Q32 Bio buyer in Q2 2019 was Bellevue Group, an estimated $30.6M added.
  • The largest Q32 Bio seller in Q2 2019 was Sphera Funds Management, an estimated $4.46M sold.

Based on aggregated 13F filings for Q2 2019.